论文部分内容阅读
支气管哮喘急性发作期加用全身性糖皮质激素已作为常规治疗,我们对30例此类患者采用一次性肌注顿克200mg,收到一定疗效,报告如下。材料和方法一、临床资料我科自1996年3月至1996年8月收治的哮喘急性发作期病人30例(无高血压病、溃疡病、糖尿病),其中男14例,女16例。年龄16～83岁。临床症状轻症患者4例,中度8例,重度和危重度18例。30例患者中有过敏性鼻炎史者16例(53％),病程2～20年。有药物过敏史者13例(43％),过敏药物分别为青霉素、磺胺、APC、去痛
Acute exacerbation of bronchial asthma with systemic glucocorticoid has been used as a routine treatment, we used 30 cases of such patients with a single intramuscular injection of 200mg, received a certain effect, the report is as follows. Materials and Methods First, the clinical data of our department from March 1996 to August 1996 admitted 30 cases of acute exacerbation of asthma patients (no hypertension, ulcer disease, diabetes), including 14 males and 16 females. Age 16 to 83 years old. 4 cases of mild clinical symptoms, moderate in 8 cases, severe and 18 cases of severe. Thirty patients had history of allergic rhinitis in 16 cases (53%), duration of 2 to 20 years. A history of drug allergy in 13 cases (43%), allergic drugs were penicillin, sulfonamides, APC, to pain